Inactive Instrument
Stemcell Holdings, Inc. Stock Other OTC
Stocks
STMM
US85858N2027
Pharmaceuticals
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Masato Ozawa
CEO | Chief Executive Officer | 67 | 2021-05-23 |
Gabriel Garcia
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kato Hirotaro
LAW | General Counsel | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 1.64M | |
| -0.52% | +3.60% | +37.79% | -1.26% | 76.75B | |
| -1.83% | +3.69% | +23.09% | +181.53% | 50.46B | |
| +1.54% | +2.37% | -6.31% | +23.71% | 48.5B | |
| +1.30% | +3.35% | -50.46% | -50.08% | 44.14B | |
| -1.00% | -1.71% | +58.01% | -24.65% | 30.53B | |
| -2.32% | -4.97% | +50.52% | +80.06% | 24.28B | |
| -3.05% | -6.09% | +103.73% | -46.23% | 22.46B | |
| +0.72% | +1.39% | -7.90% | +177.29% | 20.04B | |
| +1.13% | -5.67% | +65.36% | +120.26% | 16.14B | |
| Average | -0.42% | -0.45% | +30.42% | +51.18% | 37.03B | |
| Weighted average by Cap. | -0.39% | +1.06% | +23.27% | +40.95% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 3.34M 2.9M 2.71M 2.48M 4.69M 318M 4.75M 31.74M 12.46M 159M 12.54M 12.26M 529M | 6.18M 5.36M 5.02M 4.59M 8.67M 589M 8.79M 58.75M 23.06M 294M 23.2M 22.7M 979M |
| Net income | 1.4M 1.22M 1.14M 1.04M 1.97M 134M 1.99M 13.33M 5.23M 66.75M 5.27M 5.15M 222M | 2.41M 2.09M 1.96M 1.79M 3.38M 230M 3.43M 22.91M 8.99M 115M 9.05M 8.85M 382M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
